发明名称 |
MEDICINAL COMPOSITION FOR INHIBITING INCREASE IN BLOOD GASTRIN CONCENTRATION |
摘要 |
<p>A pyrrolopyridazine compound having a structure represented by the general formula (I) (wherein R<1> represents alkenyl, halogenoalkenyl, alkynyl, cycloalkyl, or optionally substituted cycloalkylalkyl; R<2> represents hydrogen or alkyl; R<3> represents hydrogen, alkyl, or hydroxyalkyl; R<4> represents hydrogen or alkyl; R<5> represents optionally substituted phenyl; A represents alkylene; and X represents oxygen or sulfur), a pharmacologically acceptable salt of the compound, or a pharmacologically acceptable ester of the compound. They are useful as a medicine for inhibiting the increase of blood gastrin concentration. Also provided is a medicinal composition comprising any of the pyrrolopyridazine compound, pharmacologically acceptable salt, and pharmacologically acceptable ester and a gastric hydrochloric acid secretoinhibitor having a benzimidazole skeleton. The composition is useful as a medicine for treatments for or prevention of ulcerative diseases which is reduced in side effects.</p> |
申请公布号 |
WO2004029058(A1) |
申请公布日期 |
2004.04.08 |
申请号 |
WO2003JP12263 |
申请日期 |
2003.09.25 |
申请人 |
SANKYO COMPANY, LIMITED;UBE INDUSTRIES, LTD.;ITO, KEIICHI;TOMIZAWA, ATSUYUKI;HAGIHARA, MASAHIKO;SHIBAKAWA, NOBUHIKO |
发明人 |
ITO, KEIICHI;TOMIZAWA, ATSUYUKI;HAGIHARA, MASAHIKO;SHIBAKAWA, NOBUHIKO |
分类号 |
C07D487/04;A61K31/5025;A61P1/04;A61P43/00;(IPC1-7):C07D487/04;A61K31/502 |
主分类号 |
C07D487/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|